Showing 1 - 10 of 931
There is considerable controversy about the causes of regional variations in health care expenditures. Using vignettes from patient and physician surveys linked to fee-for-service Medicare expenditures, this study asks whether patient demand-side factors or physician supply-side factors explain...
Persistent link: https://www.econbiz.de/10012905244
Health care spending varies widely across markets, yet there is little evidence that higher spending translates into better health outcomes, possibly due to endogeneity bias. The main innovation in this paper compares outcomes of patients who are exposed to different health care systems that...
Persistent link: https://www.econbiz.de/10012759916
Policymakers are increasingly interested in reducing healthcare costs and inefficiencies through innovative payment strategies. These strategies may have heterogeneous impacts across geographic areas, potentially reducing or exacerbating geographic variation in healthcare spending. In this...
Persistent link: https://www.econbiz.de/10013013190
Policies aiming to improve healthcare productivity often focus on reducing care fragmentation. Care fragmentation occurs when services are spread across many providers, potentially making coordination difficult. Using Medicare claims data, we analyze the effect of moving to a region with more...
Persistent link: https://www.econbiz.de/10012964892
We ask how patient knowledge of appropriate antibiotic usage affects both physicians prescribing behavior and the physician-patient relationship. We conduct an audit study in which a pair of simulated patients with identical flu-like complaints visits the same physician. Simulated patient A is...
Persistent link: https://www.econbiz.de/10013135233
pharmaceutical trade data from 1996 to 2005, we examine the role of China and India as suppliers of medicines to other middle- and … medicines from high- income countries. We find that imports of antibiotics and unspecified medicaments from India and China … China are not only important sources of inexpensive medicines but also have an indirect effect by lowering prices through …
Persistent link: https://www.econbiz.de/10013067622
China, Japan, and South Korea, and estimate the economic burden of chronic conditions in five domains (cardiovascular … non-communicable diseases over the period 2010-2030 are $16 trillion for China (measured in real USD with the base year …-effectiveness analysis by identifying some intervention strategies to reduce disease prevalence in China that are cost beneficial and …
Persistent link: https://www.econbiz.de/10012951354
credit and debit card transactions in China from 2013 to 2015, this paper provides to our knowledge the first analysis of the … Health Organization's annual standard of 10 mg/m3 would amount to $42 billion, or nearly 7% of China's total healthcare …
Persistent link: https://www.econbiz.de/10012916897
on physical health, while the effect on mental health is limited. Using the China Family Panel Studies (CFPS) covering 12 …
Persistent link: https://www.econbiz.de/10012916899
This paper provides estimates of the economic impact of non-communicable diseases (NCDs) in China and India for the … five main NCDs will total USD 27.8 trillion for China and USD 6.2 trillion for India (in 2010 USD). For both countries, the … that the costs are much larger in China than in India mainly because of China's higher income and older population. Rough …
Persistent link: https://www.econbiz.de/10013077651